Projects per year
Fingerprint
Dive into the research topics where Ping Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 6 Finished
-
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics
Xu, H. (PI), Denny, J. (CoPI), Warner, J. L. (CoPI) & Yang, P. (CoPI)
9/1/16 → 8/31/21
Project: Research project
-
Health and QOL among Long-Term Lung Cancer Survivors
Yang, P. (CoPI) & Yang, P. (PI)
7/20/06 → 11/30/12
Project: Research project
-
Mayo SPORE in Brain Cancer
Ballman, K. V. (CoPI), Buckner, J. C. (CoPI), Galanis, E. (CoPI), Giannini, C. (CoPI), James, C. D. (CoPI), O'neill, B. P. P. (CoPI), Sarkaria, J. N. (CoPI), Uhm, J. (CoPI), Yang, P. (CoPI), Loftus, J. C. (CoPI) & Anastasiadis, P. Z. (CoPI)
9/20/04 → 8/31/18
Project: Research project
-
Genetic Determinants of Lung Cancer Survival
Yang, P. (CoPI) & Yang, P. (PI)
9/27/01 → 1/31/14
Project: Research project
-
Alpha-1 AD Carriers and Lung Cancer Risk
Yang, P. (CoPI) & Yang, P. (PI)
3/10/00 → 9/29/11
Project: Research project
-
Genome-Wide Association Study of Gallstone Disease Identifies Novel Candidate Genomic Variants in a Latino Community of Southwest USA
Arora, A., Jack, K., Kumar, A. V., Borad, M., Girardo, M. E., De Filippis, E., Yang, P. & Dinu, V., Feb 2025, In: Journal of Racial and Ethnic Health Disparities. 12, 1, p. 234-240 7 p.Research output: Contribution to journal › Article › peer-review
-
Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities
Peng, Y., Li, D., Wampfler, J. A., Luo, Y. H., Kumar, A. V., Gu, Z., Kosuru, N., Yu, N. Y., Wang, Z., Leventakos, K., Ernani, V. & Yang, P., Feb 2025, In: Oncology reports. 53, 2, 25.Research output: Contribution to journal › Article › peer-review
-
Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort
Peng, Y., Kumar, A. V., Gu, Z., Kosuru, N., Wampfler, J. A., Reck dos Santos, P. A., Yu, N. Y., D'Cunha, J., Ernani, V., Costello, C. M. & Yang, P., Jul 2024, In: Journal of the American Academy of Dermatology. 91, 1, p. 172-175 4 p.Research output: Contribution to journal › Article › peer-review
-
Extracting Systemic Anticancer Therapy and Response Information From Clinical Notes Following the RECIST Definition
Zuo, X., Kumar, A., Shen, S., Li, J., Cong, G., Jin, E., Chen, Q., Warner, J. L., Yang, P. & Xu, H., 2024, In: JCO Clinical Cancer Informatics. 8, e2300166.Research output: Contribution to journal › Article › peer-review
-
Lung adenocarcinoma patients with ROS1-rearranged tumors by sex and smoking intensity
Peng, Y., Ernani, V., Liu, D., Guo, Q., Hopps, M., Cappelleri, J. C., Gupta, R., de Andrade, M., Chen, J., Yi, E. S. & Yang, P., Apr 15 2024, In: Heliyon. 10, 7, e28285.Research output: Contribution to journal › Article › peer-review
Open Access